| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,482 |
7,248 |
$1.50M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,519 |
3,020 |
$578K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
798 |
746 |
$200K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
427 |
422 |
$106K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
167 |
162 |
$41K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
135 |
135 |
$37K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
97 |
97 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
69 |
67 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
141 |
140 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
33 |
24 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
13 |
$687.06 |
| 36415 |
Collection of venous blood by venipuncture |
730 |
644 |
$404.85 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
27 |
26 |
$132.76 |